COVID-19

The COVID-19 pandemic caused significant disruptions to virtually all aspects of oncology care. There has been a steep drop in cancer diagnoses and screenings—a result of shelter-in-place policies instituted early on, as well as ongoing patient fears about returning to healthcare facilities for new appointments or follow-up care. Read More ›

The COVID-19 pandemic has had a profound impact on cancer care delivery in the United States—for the worse, but also for the better. Read More ›

Nationally renowned oncologist Maurie Markman, MD, President of Medicine and Science at Cancer Treatment Centers of America, led a panel of experts in discussing how existing anticancer agents, such as kinase inhibitors and the corticosteroid dexamethasone, may be used for the treatment of patients with COVID-19 in a July webinar of the Association for Value-Based Cancer Care (AVBCC) on COVID-19. Read More ›

Telemedicine has become an essential tool for urologists as they continue to provide care to their patients during the COVID-19 pandemic. However, many urologists have questions and concerns regarding the implementation of telehealth services into their practices, including issues related to financial compensation and privacy laws. Read More ›

Subscribe to Urology Practice Management

Stay up to date with urology news & updates by subscribing to receive the free UPM print publications or e‑Newsletters.

UPM
__Print - UPM